Abstract:Myocardial infarction (MI) is a leading cause of morbidity and mortality worldwide. Because mitochondrial dysfunction critically contributes to the pathogenesis of MI, intensive research is focused on the development of therapeutic strategies targeting mitochondrial homeostasis. Mitochondria possess a quality control system which maintains and restores their structure and function by regulating mitochondrial fission, fusion, biogenesis, degradation, and death. In response to slight damage such as transient hypoxia or mild oxidative stress, mitochondrial metabolism shifts from oxidative phosphorylation to glycolysis, in order to reduce oxygen consumption and maintain ATP output. Mitochondrial dynamics are also activated to modify mitochondrial shape and structure, in order to meet cardiomyocyte energy requirements through augmenting or reducing mitochondrial mass. When damaged mitochondria cannot be repaired, poorly structured mitochondria will be degraded through mitophagy, a process which is often accompanied by mitochondrial biogenesis. Once the insult is severe enough to induce lethal damage in the mitochondria and the cell, mitochondrial death pathway activation is an inevitable consequence, and the cardiomyocyte apoptosis or necrosis program will be initiated to remove damaged cells. Mitochondrial quality surveillance is a hierarchical system preserving mitochondrial function and defending cardiomyocytes against stress. A failure of this system has been regarded as one of the potential pathologies underlying MI. In this review, we discuss the recent findings focusing on the role of mitochondrial quality surveillance in MI, and highlight the available therapeutic approaches targeting mitochondrial quality surveillance during MI.

Mitochondrial quality control mechanisms as potential therapeutic targets in sepsis-induced multiple organ failure

Endothelial Cell Dysfunction and Targeted Therapeutic Drugs in Sepsis

Research progress on the role of mitochondrial quality control in sepsis associated encephalopathy

Mitochondrial dysfunction in sepsis: mechanisms and therapeutic perspectives

Mechanism of Mitophagy and Its Role in Sepsis Induced Organ Dysfunction: A Review

Potential Therapy Strategy: Targeting Mitochondrial Dysfunction in Sepsis

Therapeutic Strategies Targeting Mitochondrial Dysfunction in Sepsis-induced Cardiomyopathy

The emerging role of mtDNA release in sepsis: Current evidence and potential therapeutic targets

[Research of Progress of Mitochondria in the Pathogenesis of Sepsis].

Sepsis induced myocardial mitochondrial oxidative damage in the elderly

Mitochondrial dysfunction and resuscitation in sepsis

Progress in the Mechanism of Mitochondrial Dysfunction in Septic Cardiomyopathy

[Research progress of mitochondrial dysfunction in the pathogenesis of septic acute kidney injury].

Mitochondrial Injury and Targeted Intervention in Septic Cardiomyopathy.

Mitochondrial dysfunction and acute renal injury in sepsis

An Overview on Mitochondrial-Based Therapies in Sepsis-Related Myocardial Dysfunction: Mitochondrial Transplantation as a Promising Approach

Sepsis-Induced Myocardial Dysfunction (SIMD): the Pathophysiological Mechanisms and Therapeutic Strategies Targeting Mitochondria

Disturbance of mitochondrial dynamics and mitophagy in sepsis-induced acute kidney injury

Mitochondrial quality surveillance as a therapeutic target in myocardial infarction

Current Perspectives of Mitochondria in Sepsis-Induced Cardiomyopathy

Molecular mechanisms of Sepsis attacking the immune system and solid organs